Reach Surgical Receives CE Mark Approval for SOUND REACH™ Swift
- The leading innovative plug-and-play ultrasonic shears with integrated transducer designed for open surgery SINGAPORE, June 3, 2026 /PRNewswire/ -- Reach Surgical, the surgical solutions division of Genesis MedTech, has received CE Mark approval for SOUND REACHTM Swift, ultrasonic shears designed for open surgical procedures, including breast and thyroid surgeries. ...
HIMSS and SingHealth to Co-Host 2026 HIMSS APAC Health Conference & Exhibition in Singapore to Accelerate Healthcare Transformation
SINGAPORE, June 3, 2026 /PRNewswire/ -- HIMSS, a mission-driven independent society, global thought leader and advisor, will co-host the 2026 HIMSS APAC Health Conference & Exhibition 23–25 August 2026 in Singapore in strategic partnership with SingHealth, Singapore's largest public group of healthcare institutions. HIMSS26 APAC will convene senior health system leaders,...
Early Data Show Highly Selective FGFR2 Inhibitor 3HP-2827 Active in Advanced CCA; Chinese Academy of Sciences’ Zhou Jian Comments on Potential for Patients With FGFR2 Alterations
CHICAGO, June 2, 2026 /PRNewswire/ -- At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, 3H Pharmaceuticals released new clinical data for its wholly owned candidate, 3HP-2827. The ongoing study focuses on patients with advanced cholangiocarcinoma (CCA) and other solid tumors carrying FGFR2 alterations—an area of persistent and significant unmet need. The data showed that 3HP-2827,...
Pictor® Reports Strong Commercial Momentum One Year After Launching U.S. Headquarters
The targeted proteomic platform company marks its first anniversary in Carlsbad with four commercial partnerships, seven products, BSL-2 equipped lab, and growing adoption across human and animal health markets globally CARLSBAD, Calif., June 2, 2026 /PRNewswire/ -- As laboratories increasingly seek faster, more cost-efficient alternatives to legacy single-analyte testing, demand for scalable...
Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases
Civorebrutinib is an investigational oral, covalent reversible BTK inhibitor designed to provide differentiated efficacy, safety and convenience in immune-mediated kidney diseases Civorebrutinib adds pipeline-in-a-product potential across multiple rare kidney diseases, expanding and diversifying Travere's pipeline SHANGHAI, June 2, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery,...
SK bioscience Secures First UNICEF Procurement Contract Improving Vaccine Access
First UNICEF procurement contract strengthens SK bioscience's presence in global public procurement markets Dual-hemisphere supply programs enhance manufacturing efficiency and operational capabilities Public procurement programs drive both commercial growth and improved vaccine accessibility INCHEON, South Korea, June 2, 2026 /PRNewswire/ -- SK bioscience announced that it has been designated as...
Ping An Launches “Ping An Home” Service Brand
Advancing Proactive Health Management to Meet Chinese Families' Demand for Healthy Longevity HONG KONG and SHANGHAI, June 2, 2026 /PRNewswire/ -- As population aging accelerates and medical standards continue to advance, China is steadily entering an era of longevity. While life expectancy is increasing, improving quality of life has become a key concern for society at large. Against...
NOVI Health Partners with Novo Nordisk to Expand Access to Structured Weight Care Support in Singapore
The collaboration aims to improve access to lifestyle coaching supported, clinically guided programs for patients exploring medical weight care. SINGAPORE, June 2, 2026 /PRNewswire/ -- NOVI Health today announced a strategic partnership with Novo Nordisk aimed at providing greater access to physician-led, structured weight loss programs that incorporate personalised health coaching support. For many Singaporeans, the struggle with weight is...
NYB.AI Launches Vecura 2.0, Bringing Agentic AI Workflows to Molecular Discovery, with NVIDIA
TAIPEI, June 2, 2026 /PRNewswire/ -- Life science research is entering an AI era, but most discovery teams still cannot use frontier models at scale. Advanced AI models, molecular simulation tools, scientific databases, inference optimization and GPU infrastructure remain fragmented across separate systems. For many pharmaceutical companies, ingredient innovators, biotech teams, and research groups, this makes AI adoption slow,...
Chinese Orthopaedic Robot KUNWU® Lands in Brazil, Completing First Clinical Surgery in an International Hospital
HONG KONG, June 2, 2026 /PRNewswire/ -- On 29 May (Brazil local time), an orthopaedic surgical robot from Shenzhen, China, completed its first clinical launch in an international hospital inside an operating theatre at Santa Casa de Jaú Hospital in Jaú, São Paulo. Independently developed by Yuanhua Robotics, Perception and AI Technologies Ltd. (hereinafter referred to as "Yuanhua Tech"),...
